文献速递儿科与产科急症复苏、休克与脓毒症

妊娠期出血行主动脉球囊阻断的胎儿与新生儿结局:文献综述

Fetal and neonatal outcomes following maternal aortic balloon occlusion for hemorrhage in pregnancy: A review of the literature.
PubMed 文献 · J Trauma Acute Care Surg · 2022-01-01
一句话结论产科出血使用主动脉球囊阻断可能减少失血和子宫切除率,且各研究中未观察到胎儿/新生儿结局差异,但仅13.5%病例在分娩前阻断,安全性待进一步研究。

本文为文献综述,纳入21篇报告共825例产科出血行主动脉球囊阻断(ABO)的病例,其中13.5%(111/825)在胎儿分娩前行主动脉阻断。对比队列包括448例接受髂动脉球囊阻断(n=219)或无血管球囊阻断(n=229)的患者。各研究报告的最常见新生儿结局为Apgar评分,ABO与非ABO患者间胎儿/新生儿结局无差异。五项对比研究报道ABO患者失血量显著减少,四项研究报道子宫切除率显著降低。ABO相关并发症发生率为1.6%(13/825),一例孕24周创伤孕妇使用ABO后发生新生儿死亡,一例产妇因主动脉夹层死亡。

要点

  • 产科出血行ABO的825例中,仅13.5%(111/825)在分娩前阻断主动脉,该时机安全性需进一步研究确定。
  • 各研究中ABO与非ABO患者的胎儿/新生儿结局(最常见为Apgar评分)无差异。
  • 五项对比研究报道ABO患者失血量显著减少,四项研究报道子宫切除率显著降低。
  • ABO相关并发症发生率为1.6%(13/825),包括一例产妇因主动脉夹层死亡。
  • 唯一报道的孕24周创伤孕妇使用ABO病例发生一例新生儿死亡。

适用人群与场景

  • 产科出血或创伤性出血的孕妇,病例需报告胎儿/新生儿结局方被纳入综述。
  • 对比队列包括接受髂动脉球囊阻断(n=219)或无血管球囊阻断(n=229)的产科出血患者。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 主动脉球囊阻断(ABO),包括复苏性血管内球囊阻断,用于产科出血;球囊充盈时机分为分娩前或分娩后,原文未给出具体剂量或操作参数。

红旗征与不能漏的情况

  • ABO相关并发症发生率为1.6%(13/825),包括一例产妇因主动脉夹层死亡。
  • 唯一报道的孕24周创伤孕妇使用ABO病例发生一例新生儿死亡。

研究设计与关键结果

  • 对比队列包括448例接受髂动脉球囊阻断(n=219)或无血管球囊阻断(n=229)的患者。
  • 各研究报告的最常见新生儿结局为Apgar评分,ABO与非ABO患者间胎儿/新生儿结局无差异(原文未提供具体数值)。
  • ABO相关并发症发生率为1.6%(13/825),一例产妇因主动脉夹层死亡;唯一报道的孕24周创伤孕妇使用ABO病例发生一例新生儿死亡。

证据类型、等级与局限

  • 局限:原文未提及具体局限,但设计上为综述,纳入研究以病例报告/系列和对比研究为主,缺乏随机对照试验。

对床旁实践的改变

  • 产科出血时ABO可能减少失血和降低子宫切除率,且各研究中未观察到胎儿/新生儿结局差异,但仅13.5%病例在分娩前阻断,分娩前主动脉阻断的安全性需进一步研究确定。
  • ABO相关并发症发生率为1.6%(13/825),包括主动脉夹层死亡,使用时应警惕血管并发症。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Hemorrhage is a leading cause of maternal death worldwide, with increased risk in women with abnormal placentation. Aortic balloon occlusion (ABO), including resuscitative endovascular balloon occlusion, has been used for obstetrical hemorrhage for 20 years, and is associated with decreased operative blood loss, fewer transfusions, and lower rates of hysterectomy. However, the effect of aortic occlusion on fetal/neonatal outcomes is not well known.

METHODS: A literature review on ABO for obstetrical or traumatic hemorrhage was performed. Cases were included if fetal/neonatal outcomes were reported. Data were collected on timing of balloon inflation (predelivery or postdelivery), fetal/neonatal mortality, and Apgar scores. Secondary maternal outcomes included blood loss, need for hysterectomy, ABO-related complications, and mortality.

RESULTS: Twenty-one reports of ABO in 825 cases of obstetrical hemorrhage were reviewed (nine case reports/series and twelve comparative studies). 13.5% (111/825) had aortic occlusion prior to delivery of the fetus. Comparative cohorts included 448 patients who underwent iliac artery balloon occlusion (n = 219) or no vascular balloon occlusion (n = 229). The most common neonatal outcome reported was Apgar scores, with no difference in fetal/neonatal outcomes between ABO and non-ABO patients in any study. One neonatal mortality occurred in the sole reported case of ABO use in a pregnant trauma patient at 24 weeks gestation. One maternal mortality occurred because of aortic dissection. Five comparative studies reported significantly decreased blood loss in ABO patients compared to non-ABO patients, and four studies reported significantly lower rates of hysterectomy in ABO patients. ABO-related complications were reported in 1.6% of patients (13/825).

CONCLUSION: Obstetrical hemorrhage is a devastating complication, and ABO may potentially decrease blood loss and reduce the hysterectomy rate without compromising fetal and neonatal outcomes. Further research is needed to determine the safety of predelivery aortic occlusion as this occurred in 14% of the cases.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Theodorou CM, Rinderknecht TN, Girda E, et al. Fetal and neonatal outcomes following maternal aortic balloon occlusion for hemorrhage in pregnancy: A review of the literature. J Trauma Acute Care Surg. 2022. PMID: 34561397. doi:10.1097/TA.0000000000003420

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。